Disc Medicine, Inc. (IRON)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 26.52 |
| Open | 26.55 |
| Bid | 27.45 x 100 |
| Ask | 27.59 x 100 |
| Day's range | 25.64 - 27.90 |
| 52-week range | 25.60 - 77.60 |
| Volume | |
| Avg. volume | 460,644 |
| Market cap | 679.962M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.42 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 57.11 |
ZacksBiotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Disc Medicine, Inc. (IRON) and Verve Therapeutics (VERV) fall on study updates.
ZacksDisc Medicine (IRON) Down on Mixed Results From AURORA Study
Disc Medicine's (IRON) shares lose after a phase II study of bitopertin in patients with erythropoietic protoporphyria does not achieve the key secondary endpoint.
Investor's Business DailyDisc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study
Disc's light sensitivity drug succeeded in a test Monday, but a large placebo response confounded the results. The biotech stock plummeted.
© 2024 Yahoo. All rights reserved.